Your location：Home >News center >Industry News
Industry News
11-302021
Sitagliptin - First In Class DPP4 Inhibit…
Sitagliptin, the first oral DPP-4 inhibitor to be marketed for treating Type 2 Diabetes
11-202021
What Are PEG Linkers and Their Applicatio…
Learn more detailes about PEG linkers and its applications in pharmaceutical field.
11-162021
Ten Most Popular Anti-cancer Drugs In 202…
In view of the complexity of cancer treatment and peoples needs, the market prospects of anti-tumor drugs are broad. Many pharmaceutical and biotechnology companies have stepped up research a…
08-282021
Antibody-Drug Conjugates for Cancer Thera…
Antibody-drug conjugates (ADCs) are a rapidly evolving class of anticancer therapeutics consisting of antibodies attached to potent cytotoxic drugs via chemical linkers.
05-112021
CDK4/6 Inhibitors for Treatment of Advanc…
There are three CDK4/6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib approved by FDA to treat Advanced Breast Cancer.
sales@huatengusa.com
+86 0731 89916275